- REGN +0.06%
Regeneron Pharmaceuticals (NASDAQ:REGN) stock performs better than its underlying earnings growth over last five years
Yahoo Finance · 2 weeks ago
Open | 1,082.64 |
High | 1,092.46 |
Low | 1,066.92 |
Mkt Cap | 118.76B |
P/E (TTM) | 31.85 |
Div & Yield | N/A & N/A |
Prev. Close | 1,077.19 |
52 Wk. Low | 726.12 |
52 Wk. High | 1,106.16 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 3.15B | 0.50% ▼ |
Net Income | 722M | 11.70% ▼ |
Diluted EPS | 9.55 | 12.60% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $10.61 | - |
Q1 2024 | $10.09 | $9.55 |
Q4 2023 | $10.73 | $11.86 |
S&P FuturesES=F | 5,501.50+29.00 (+0.53%) |
Dow FuturesYM=F | 40,924.00-35.00 (-0.09%) |
Nasdaq FuturesNQ=F | 19,144.25+208.00 (+1.10%) |
422.92-0.89% | |
138.44-0.94% | |
103.73-7.04% |